Michael Newman

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ Michael Newman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Newman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Indaptus Therapeutics, Inc. CSO and Director, Director Common Stock 101,074 $205,180 $2.03 22 Dec 2025 Direct

Insider Reports Filed by Michael Newman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INDP Indaptus Therapeutics, Inc. 22 Dec 2025 1 +$105,974 4 CSO and Director, Director 29 Dec 2025, 16:01
INDP Indaptus Therapeutics, Inc. 09 Oct 2024 1 $0 4 CSO and Director, Director, 10%+ Owner 10 Oct 2024, 16:05
INDP Indaptus Therapeutics, Inc. 22 Jan 2024 1 $0 4 CSO and Director, Director, 10%+ Owner 23 Jan 2024, 16:15
INDP Indaptus Therapeutics, Inc. 18 Jan 2023 1 $0 4 CSO and Director, Director, 10%+ Owner 20 Jan 2023, 15:05
INDP Indaptus Therapeutics, Inc. 31 Jan 2022 2 -$100,043 4 CSO and Director, Director, 10%+ Owner 02 Feb 2022, 16:08
INDP Indaptus Therapeutics, Inc. 26 Jan 2022 1 $0 4 CSO and Director, Director, 10%+ Owner 28 Jan 2022, 15:31
INDP Indaptus Therapeutics, Inc. 04 Aug 2021 1 $0 4 CSO and Director, Director, 10%+ Owner 06 Aug 2021, 17:00
INDP Indaptus Therapeutics, Inc. 03 Aug 2021 0 $0 3 Chief Scientific Officer, Director, 10%+ Owner 06 Aug 2021, 16:35